期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
Novel molecular mechanisms of immune evasion in hepatocellular carcinoma: NSUN2-mediated increase of SOAT2 RNA methylation
1
作者 Jinhua Jiang Feng Liu +4 位作者 Dan Cui Caixia Xu Jiachang Chi Tinghua Yan Fang Guo 《Cancer Communications》 2025年第7期846-879,共34页
Background:Hepatocellular carcinoma(HCC)is a deadly malignancy known for its ability to evade immune surveillance.NOP2/Sun RNA methyltransferase family member 2(NSUN2),an RNA methyltransferase involved in carcinogenes... Background:Hepatocellular carcinoma(HCC)is a deadly malignancy known for its ability to evade immune surveillance.NOP2/Sun RNA methyltransferase family member 2(NSUN2),an RNA methyltransferase involved in carcinogenesis,has been associated with immune evasion and energy metabolism reprogramming.This study aimed to examine the molecular mechanisms underlying the involvement of NSUN2 in immune evasion and metabolic reprogramming of HCC.Methods:Single-cell transcriptomic sequencing was applied to examine cellular composition changes,particularly immune cell dynamics,in HCC and adjacent normal tissues.Bulk RNA-seq and proteomics identified key genes and proteins.Methylation sequencing and methylated RNA immunoprecipitation(MeRIP)were carried out to characterize the role of NSUN2 in 5-methylcytosine(m5C)modification of sterol O-acyltransferase 2(SOAT2).Clinical samples from 30 HCC patients were analyzed using reverse transcription-quantitative polymerase chain reaction and Western blotting.Gene expression was manipulated using CRISPR/Cas9 and lentiviral vectors.In vitro co-culture models and metabolomics were used to study HCC cell-T cell interactions,energy metabolism,and immune evasion.Tumor growth in an orthotopic mouse model was monitored by bioluminescence imaging,with subsequent measurements of tumor weight,volume,and immunohistochemical staining.Results:Single-cell transcriptomic analysis identified a marked increase in malignant cells in HCC tissues.Cell communication analysis indicated that tumor cells might promote cancer progression by evading immune clearance.Multi-omics analyses identified NSUN2 as a key regulator in HCC development.MeRIP confirmed that NSUN2 facilitated the m5C modification of SOAT2.Analysis of human HCC tissue samples demonstrated pronounced upregulation of NSUN2 and SOAT2,along with elevated m5C levels in HCC tissues.In vitro experiments uncovered that NSUN2 augmented the reprogramming of energy metabolism and repressed the activity and cytotoxicity of CD8+T cells,contributing to immune evasion.In vivo studies further substantiated the role of NSUN2 in fostering immune evasion and tumor formation of HCC by modulating the m5C modification of SOAT2.Conclusions:The findings highlight the critical role of NSUN2 in driving HCC progression through the regulation of m5C modification on SOAT2.These findings present potential molecular markers for HCC diagnosis and therapeutic targets for its treatment. 展开更多
关键词 5-methylcytosine modification energy metabolism reprogramming Hepatocellular carcinoma immune escape NSUN2 soat2
原文传递
肠道降脂药物新靶点SOAT2介导脂质摄取抑制和降脂作用
2
作者 梁静佳 邵文涛 顾爱华 《科学通报》 EI CAS CSCD 北大核心 2023年第16期2124-2132,共9页
目前,已发现的靶向抑制肠道脂质摄取的降脂药物作用大多局限于胆固醇,达不到预期的降脂效果,且具有一定的副作用.因此,寻找能同时有效抑制肠道脂肪酸和胆固醇摄取的新药物及新靶点是可行的新策略.为了寻找和筛选对肠道脂质摄取具有抑制... 目前,已发现的靶向抑制肠道脂质摄取的降脂药物作用大多局限于胆固醇,达不到预期的降脂效果,且具有一定的副作用.因此,寻找能同时有效抑制肠道脂肪酸和胆固醇摄取的新药物及新靶点是可行的新策略.为了寻找和筛选对肠道脂质摄取具有抑制效应的天然化合物,本文构建了基于脂质摄取和转化的荧光高通量体外双评价体系.经过对104个天然化合物的筛选发现,盐酸小檗碱(BBR)的效应最为明显,且对肠道胆固醇和脂肪酸摄取的双重抑制作用均呈现时间-剂量依赖性.此外,随着剂量和处理时间的增加,BBR可以显著抑制酰基辅酶A:胆固醇酰基转移酶2(SOAT2)的表达.进一步通过SOAT2干扰实验证实,SOAT2特异性介导了BBR对脂质摄取的抑制作用,并发现SOAT2可能是同时调控胆固醇与脂肪酸摄取的关键靶点.因此,本研究通过利用高通量筛选体系,为降脂药物筛选提供了新策略,并提出肠道SOAT2可能是一种潜在的降脂新靶点,可用于筛选和寻找更安全有效的治疗药物,同时也为BBR的临床应用提供了新的证据支持. 展开更多
关键词 肠道降脂药 筛选模型 酰基辅酶A:胆固醇酰基转移酶2(soat2) 肠道脂质摄取 盐酸小檗碱
原文传递
盐酸小檗碱缓解代谢相关性脂肪肝病的生物学靶点和机制 被引量:2
3
作者 梁静佳 顾爱华 《科学通报》 EI CAS CSCD 北大核心 2023年第5期469-478,共10页
代谢相关性脂肪肝疾病(metabolic associated fatty liver disease, MAFLD)是一种全球性常见疾病,与心血管疾病、肥胖、糖尿病等多种代谢疾病密切相关.临床防治较为复杂.目前发现的研究药物,包括抗氧化剂、胰岛素增敏剂和降脂药物等,虽... 代谢相关性脂肪肝疾病(metabolic associated fatty liver disease, MAFLD)是一种全球性常见疾病,与心血管疾病、肥胖、糖尿病等多种代谢疾病密切相关.临床防治较为复杂.目前发现的研究药物,包括抗氧化剂、胰岛素增敏剂和降脂药物等,虽然在降低肝脏脂肪含量和部分组织学病变方面取得了一定的疗效,但在缓解肝脏纤维化方面效果有限.盐酸小檗碱(berberine, BBR)是一种异喹啉生物碱,来源于许多药用植物,早期被用作一种抗腹泻药物使用,目前大量研究显示其在保护心血管疾病、抗癌等方面具有丰富的药理作用.越来越多的研究发现, BBR具有调节代谢和保护肝脏的作用. BBR可以通过调节肝脏脂质代谢、改善胰岛素抵抗等途径改善MAFLD.但是药代动力学实验发现, BBR的吸收和首次消除主要发生在小肠,超过99%的BBR最终不会进入血液循环.由此推测, BBR主要在肠道发挥其缓解肝脏脂肪变性的生物效应,但具体机制和靶点尚不明确.有研究指出, BBR对肠道微环境改善和肠道脂质摄取抑制的作用可能是BBR缓解MAFLD的关键机制.本文综述了BBR的药代动力学、调节肝脏脂质代谢、缓解肝脏炎症及氧化应激等生物学效应和机制,并提出了BBR通过改善肠道微环境、抑制肠道脂质摄取从而缓解MAFLD的潜在生物学靶点. 展开更多
关键词 盐酸小檗碱 代谢相关性脂肪肝病 脂肪酸 肠道摄取 soat2 CD36
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部